Persistence Pays Off For Chiasma And Its Oral Acromegaly Therapy

 
• By Alexandra Shimmings

Chiasma has bounced back from a 2016 CRL for Mycapssa with a new SPA-agreed Phase III trial meeting all its primary and secondary endpoints. The product is positioned to be the first oral treatment for acromegaly.

Web
If at first you don't succeed, try, try again • Source: Shutterstock

More from Clinical Trials

More from R&D